Loading
Induct AS Stock: price and insider trades · Norway
No insider purchase over the last 90 days. The latest was filed 22 May 2026.
Induct AS: what insiders have been doing
Induct AS belongs to the Health Care sector. Filings by its managers are published through Oslo Børs. 4 insiders have disclosed 4 filings since 18 October 2025.
Purchases and sales both appear in the filings: 1 purchase (1 insider, €4,464) and 1 sale (1 insider). The amount is not disclosed for 1 filing. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. At €4,464, the purchase published on 22 May 2026 by Synnøve Jacobsen is the largest of the period.
Across the 257 companies tracked on its exchange, the median is 4 filings; at 4 filings, this issuer sits right on that mark. The full history, which starts in 2021, counts 5 purchases against 3 sales.
The most recent open-market purchase was published on 22 May 2026, 148 days ago.
Elsewhere in the same sector, our signals recently picked up insider purchases at Cooper Companies, Inc. and Cytosorbents Corp. These figures are compiled from regulatory filings published by Oslo Børs. They describe what insiders did and are not a recommendation.
Insider Decl.
20
Thresholds
n/a
Buy Volume
€4,464
5 ops. · all time
Sell Volume
€10,400
3 ops. · all time
Who traded when
BuySaleSynnøve Jacobsen2 buys
Unknown insider (INDCT)2 buys
CTO Ignacio Orteu's1 sale
Norwegian Securities Trading Act.1 sale
Since the insiders bought
- -73.4%Entry NOK 2.26 · Close 13 Oct 2026 NOK 0.60
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Fundamental score
Ranked 15,356 of 24,148 companies
43.0
score / 100
Value39
Quality47
FCF yld-12%
Earn yld-25%
EV/EBITDA4.4x
ROE-25%
Gross mgn93%
Net mgn-48%
Debt/EBITDA0.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
NOK 0.60
Analyst consensus
1 analysts2.00/5
NOK 1.00Target NOK 1.00(+67%)NOK 1.00
Income statement
RevenueNOK 14.8M
Gross profitNOK 13.7M93% margin
EBITDANOK 7.3M49% margin
Net income-NOK 7.1M-78.9% margin
Valuation
PER (forward)-5.0x
P/Book0.5x
Beta0.34
Balance sheet & cash
Market capNOK 30.2M
Total debtNOK 3.6M
Free Cash Flow-NOK 3.3M
Debt / Equity24%
Profitability & ownership
ROE-24.5%
ROA-9.9%
% insiders39.2%
% institutions1.7%
Last declaration on 6 September 2026
Declarations20 total
110,000 shares@ NOK 0.630.25% mcap100.0% of flowShareMERKOSLO:681700
ShareMERKOSLO:680404
ShareMERKOSLO:678687
23,456 shares@ NOK 2.04100.0% of flowShareMERKOSLO:674266
Canonical exit: 20 Aug 2026 (T+90)
2.085 sharesShareMERKOSLO:651171
9.39 sharesShareMERKOSLO:646936
9.39 sharesShareMERKOSLO:646934
20,000 shares@ NOK 6.00100.0% of flowShareMERKOSLO:645625
7.031 sharesShareMERKOSLO:642088
10 sharesShareMERKOSLO:641357
10,000 sharesShareMERKOSLO:637687
Canonical exit: 5 May 2025 (T+90)
18.175 shares@ NOK 5.1802100.0% of flowShareMERKOSLO:582847
@ €0.6744ShareMERKOSLO:554291
10,000 shares@ NOK 8.30100.0% of flowShareMERKOSLO:532984
11,500 shares@ NOK 8.73100.0% of flowShareMERKOSLO:532638
20 of 20 declarations
About Induct AS
Induct AS is a company operating in the healthcare and pharmaceutical sector, specializing in the development of innovative solutions. It is listed on the XOSL market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
